Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia (CROSBI ID 322810)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Papić, Neven ; Radmanić, Leona ; Dušek, Davorka ; Kurelac, Ivan ; Židovec Lepej, Snježana ; Vince, Adriana Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia // Infectious disease reports, 12 (2020), 3; 74-81. doi: 10.3390/idr12030016

Podaci o odgovornosti

Papić, Neven ; Radmanić, Leona ; Dušek, Davorka ; Kurelac, Ivan ; Židovec Lepej, Snježana ; Vince, Adriana

engleski

Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia

Late presentation to care is the major obstacle to receiving treatment for chronic hepatitis C (CHC). Our aim was to analyze the prevalence and trends of late presenters (LP) at first consultations in Croatia during a 10-year period. This retrospective cross-sectional study included all adult CHC patients (n = 854) entering specialist medical care at the University Hospital for Infectious Diseases Zagreb between 2009 and 2018. LP was defined as liver stiffness measurement ≥ 9.5 kPa or biopsy METAVIR F ≥ 3. During the study period, mean patients’ age increased from 37 to 52 years while HCV genotype distribution changed leading to the replacement of genotype 1b with 1a (g1b 32% to 21% ; g1a 19% to 38%). A total of 320 (37.4%) were LP ; they were older (47.5, IQR 40.5– 57.6), and more commonly infected with g1b (34.1%) and g3 (42.5%). The prevalence of LP significantly increased from 31.9% in 2009 to 46.5% in 2018. Late presentation for care of CHC is increasing in Croatia suggesting a gap of diagnosing strategies in patients over 50 years.

Chronic hepatitis C ; HCV ; liver cirrhosis ; late presenters ; end stage liver disease

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12 (3)

2020.

74-81

objavljeno

2036-7449

10.3390/idr12030016

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost